Pay in 4 interest-free payments of $7.08 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Clinical profile and treatment patterns in individuals with type 2 diabetes and chronic kidney disease who initiate a GLP-1 receptor agonist: a multinational cohort study
doi: 10.3389/fneur.2024.1356662 Received 15 December 2023 Accepted 10 May 2024 Published 19 June 2024 Volume 15 - 2024 Edited by Dominic D'Agostino, University of South Florida, United States Reviewed by Anandakumar Shunmugavel, Case Western Reserve University, United States Xuehua Liu, Capital Medical University, China Updates Copyright 2024 Fogarty and Harch
Available from: UpToDate Lexi-Drugs
But "safe" comes with conditions
No change in appetite suppression
These medicines can help with blood sugar control and weight loss, but they can also cause digestive symptoms and, in some cases, more serious complications that need quick medical evaluation
US$ 29.22
US$ 22.51
US$ 26.57
